Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma
Status:
Completed
Trial end date:
2016-11-30
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine the highest dose of a drug called
bortezomib that can be given with a drug called G-CSF before stem cell collection to help in
the mobilization of stem cells.